Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Jiangdong Huo; Audrey Le Bas; Reinis R Ruza; Helen M E Duyvesteyn; Halina Mikolajek; Tomas Malinauskas; Tiong Kit Tan; Pramila Rijal; Maud Dumoux; Philip N Ward; Jingshan Ren; Daming Zhou; Peter J Harrison; Miriam Weckener; Daniel K Clare; Vinod K Vogirala; Julika Radecke; Lucile Moynié; Yuguang Zhao; Javier Gilbert-Jaramillo; Michael L Knight; Julia A Tree; Karen R Buttigieg; Naomi Coombes; Michael J Elmore; Miles W Carroll; Loic Carrique; Pranav N M Shah; William James; Alain R Townsend; David I Stuart; Raymond J Owens; James H Naismith

doi:10.1038/s41594-020-00527-9

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Nat Struct Mol Biol. 2020 Nov;27(11):1094. doi: 10.1038/s41594-020-00527-9.

Authors

Jiangdong Huo^{1

2

3}, Audrey Le Bas^{2

3}, Reinis R Ruza², Helen M E Duyvesteyn², Halina Mikolajek⁴, Tomas Malinauskas², Tiong Kit Tan⁵, Pramila Rijal^{5

6}, Maud Dumoux¹, Philip N Ward^{2

3}, Jingshan Ren², Daming Zhou², Peter J Harrison^{2

3}, Miriam Weckener¹, Daniel K Clare⁴, Vinod K Vogirala⁴, Julika Radecke⁴, Lucile Moynié¹, Yuguang Zhao², Javier Gilbert-Jaramillo⁷, Michael L Knight⁷, Julia A Tree⁸, Karen R Buttigieg⁸, Naomi Coombes⁸, Michael J Elmore⁸, Miles W Carroll⁸, Loic Carrique², Pranav N M Shah², William James⁷, Alain R Townsend^{5

6}, David I Stuart^{2

4}, Raymond J Owens^{9

10

11}, James H Naismith^{12

13

14}

Affiliations

¹ Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK.
² Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK.
³ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK.
⁴ Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, UK.
⁵ MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
⁶ Centre for Translational Immunology, Chinse Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK.
⁷ Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
⁸ National Infection Service, Public Health England, Porton Down, Salisbury, UK.
⁹ Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
¹⁰ Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. raymond.owens@rc-harwell.ac.uk.
¹¹ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK. raymond.owens@rc-harwell.ac.uk.
¹² Structural Biology, The Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.
¹³ Division of Structural Biology, University of Oxford, The Wellcome Centre for Human Genetics, Headington, Oxford, UK. naismith@strubi.ox.ac.uk.
¹⁴ Protein Production UK, The Rosalind Franklin Institute - Diamond Light Source, The Research Complex at Harwell, Harwell Science & Innovation Campus, Didcot, UK. naismith@strubi.ox.ac.uk.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding